窖蛋白(CAV1)多克隆抗體
Polyclonal Antibody to Caveolin 1 (CAV1)
VIP21; Caveolae Protein 22kDa
- 編號PAA214Hu08
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 CPA214Hu21-窖蛋白(CAV1)卵白蛋白偶聯(lián)物
- 緩沖液成份磷酸鹽緩沖液(pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 623 ¥ 1453 ¥ 2076 ¥ 5190 ¥ 20760
- 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對CAV1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別CAV1。
用法
免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA214Hu01 | 窖蛋白(CAV1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA214Hu21 | 窖蛋白(CAV1)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA214Hu08 | 窖蛋白(CAV1)多克隆抗體 | WB; IHC; ICC; IP. |
PAA214Hu01 | 窖蛋白(CAV1)多克隆抗體 | WB; IHC; FCM |
MAA214Hu22 | 窖蛋白(CAV1)單克隆抗體 | WB; IHC; ICC; IP. |
SEA214Hu | 窖蛋白(CAV1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA214Hu | 窖蛋白(CAV1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA214Hu01 | 窖蛋白(CAV1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Mendel Net | Novel prostate cancer tumour markers in a cell line model [Mendelu: source] |
Oncology reports | Caveolin-1 as a potential high-risk prostate cancer biomarker [PubMed: 22159333] |
Anticancer Research | Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men [Pubmed: 23645736] |
Sarcoidosis Vasc Diffuse Lung Dis.? | Decrased sputum caveolin-1 is associated with systemic sclerosis related lung disease [Pubmed:24751454] |
Cancer Genomics and Proteomics | Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression [PubMed: 26543085] |
Atherosclerosis | Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction [Pubmed:26775120] |
Arthritis Research & Therapy | Increased caveolin-1 in intervertebral disc degeneration facilitates repair [Pubmed:26939667] |
Oxid Med Cell Longev | Lower Serum Caveolin-1 Is Associated with Cerebral Microbleeds in Patients with Acute Ischemic Stroke [Pubmed:27119011] |
Inflammation | Caveolin-1?Promotes?the?Imbalance?of?Th17/Treg?in?Patients?with?Chronic?Obstructive?PulmonaryDisease. [pubmed:27613621] |
Oxidative Medicine and Cellular Longevity | Swim Training Modulates Skeletal Muscle Energy Metabolism, Oxidative Stress, and Mitochondrial Cholesterol Content in Amyotrophic Lateral Sclerosis Mice [Pubmed:29849903] |
Microcirculation | Endothelium‐dependent hyperpolarization‐mediated vasodilatation compensates nitric oxide‐mediated endothelial dysfunction during ischemia in diabetes‐induced?… [Pubmed:29665152] |
Genetic Testing and Molecular Biomarkers | The CAV1 Gene 3′ Untranslated Region Single Nucleotide Polymorphisms Are Associated with the Risk of Pulmonary Hypertension in Chinese Han Chronic?… [] |
Cell Rep | SIRT6 transcriptionally regulates fatty acid transport by suppressing PPAR|? [34077730] |
researchsquare | Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of Rt-PA??- [] |
Molecules | 5, 2′-Dibromo-2, 4′, 5′-trihydroxydiphenylmethanone Inhibits LPS-Induced Vascular Inflammation by Targeting the Cav1 Protein [Pubmed:35566232] |